-
Why Does Tangie Smell So Fruity? Non-Terpene Compounds Include Guava, Papaya And Passionfruit
Monday, May 6, 2024 - 2:06pm | 462Read More...In a significant finding, Abstrax Tech's research has unveiled a new class of compounds associated with the unique citrus and tropical scents found in specific cannabis strains. These compounds, identified by the terpene provider, are distinct from commonly known terpenes such as d-Limonene and...
-
Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'
Thursday, April 20, 2023 - 8:40pm | 497Read More...A new study has confirmed that pot-smoking bipeds are not the only creatures that get the munchies. Worms apparently experience cravings for their favorite snacks after consuming cannabis. Researchers at the University of Oregon said the tiny nematode worms they used for the...
-
What Are Cannabinoids, Their Types, And Effects?
Sunday, March 5, 2023 - 10:00am | 2758Read More...This article was originally published on Askgrowers and appears here with permission. Marijuana lovers already know that cannabis contains THC and CBD. The percentage of these cannabinoids decides the weed characteristics. But in fact, there are many more cannabinoids definitions than just two....
-
Botanical Ingredient Producer Linnea SA Celebrates 40 Years
Tuesday, July 19, 2022 - 1:22pm | 734Read More...The global cannabinoid market is projected to grow from $28.26 billion in 2021 to $197.74 billion in 2028 at a compound annual growth rate, CAGR, of 32.04%. One mature and seasoned company that entered the market in 2016 is Linnea SA. This year marks Linnea’s 40th anniversary...
-
Incannex's Cannabinoid Combo Product Reduces AHI In Sleep Apnea Patients
Thursday, March 10, 2022 - 12:43pm | 316Read More...Incannex Healthcare Limited (NASDAQ: IXHL) has completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA). The clinical trial assessed three doses of IHL-42X at reducing the apnoea hypopnoea index...
-
The Bio Revolution of Medical Cannabinoid Therapeutics
Saturday, September 11, 2021 - 3:44pm | 1069Read More...The world is rapidly changing, demanding Higher Quality, Less expensive food, drugs and other high compounds be produced sustainably. The challenge is being met a in a significant way through cross pollination of Biosynthesis, Engineering and DNA According to Raymond James Cannabinoid Biosynthesis...
-
Why Cannabinoids Are Here To Stay
Thursday, March 18, 2021 - 1:50pm | 1116Read More...By Roy Lipski The consumer goods business has seen its share of fads—and then some. Often it seems that not a day goes by when a special ingredient or other differentiator hailed as “transformative,” “groundbreaking” and “game-changing” simply fades away,...
-
What Is Cannabichromene?
Thursday, February 11, 2021 - 12:08pm | 283Read More...This article was originally published on The Medical Cannabis Community, and appears here with permission. CBC (Cannabichromene) is a cannabinoid that’s not often talked about. While many cultivators don’t list it on the label with THC and CBD it still exists in different strains...
-
The Next Big Cannabinoids
Monday, December 16, 2019 - 9:42am | 1296Read More...By SōRSE Technology There's no escaping it: Right now, CBD is in. Offering the medicinal appeal of cannabis without intoxicating effects, CBD is finding its way into virtually anything. Even after the buzz subsides and the conversation becomes more realistic and nuanced, the cannabinoid is...
-
CBD Biotech Company Demetrix Raises $50M In Series A Funding Round
Thursday, July 11, 2019 - 7:31am | 228Read More...Cannabinoid-focused biotechnology company Demetrix announced Thursday it secured $50 million in a Series A funding round led by Tuatara Capital. Another investor is Horizons Ventures, which previously led Demetrix's $11 million Series Seed round. Demetrix aims to develop a technology that would...
-
Canopy Growth Acquires Germany-Based C3 Cannabinoid Compound Company For $254M
Thursday, May 2, 2019 - 1:37pm | 366Read More...Canopy Growth Corp (NYSE: CGC) is strengthening its presence in Germany and Europe with the acquisition of C3 Cannabinoid Compound Company, a leading manufacturer and distributor of dronabinol, a synthetic cannabinoid. What Happened The value of the transaction is 225.9 million euro (about $254...
-
Uji Capital's Broderick Donates $9M To Harvard, MIT For Cannabinoid Research
Wednesday, May 1, 2019 - 3:46pm | 376Read More...Harvard and MIT will receive $4.5 million each for cannabinoid research. The donation comes from the universities' alumnus Charles Broderick, the managing director of Uji Capital, a New York family office with extensive investments in the cannabis industry. What Happened Harvard Medical School...
-
Vireo Health International Receives Patent For Tobacco With Cannabinoid Additives
Thursday, April 25, 2019 - 4:09pm | 359Read More...Vireo Health International (OTC: VREOF) said Thursday that the United States Patent and Trademark Office has issued a Notice of Allowance for its patent application for less-harmful tobacco products infused with cannabinoids. What Happened The patent is titled "Tobacco Products with...
-
Tilray To Buy Hemp Food Company Manitoba Harvest For $317M
Wednesday, February 20, 2019 - 8:49am | 401Read More...Cannabis company Tilray Inc. (NASDAQ: TLRY) will expand its operations into the United States and Canada hemp industry through the acquisition of FHF Holdings Ltd., also known as Manitoba Harvest, from Compass Diversified Holdings (NYSE: CODI) and other shareholders. The Details Tilray will pay up...
-
Pioneering Study To Assess Hemp-Derived Cannabinoids In Brain Injury Recovery
Tuesday, February 19, 2019 - 3:50pm | 328Read More...The first clinical study assessing the effectiveness of hemp-derived cannabinoids in recovery from brain injury will be launched in the U.S. as part of a collaboration between the Flowering HOPE Foundation and Clover Leaf University. What Happened The study is sponsored by Real Time Diagnostics...
















